Revenue (Quarterly) Chart

View Revenue (Quarterly) for AKRTF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 1.367B
March 31, 2026 1.365B
December 31, 2025 1.644B
September 30, 2025 1.653B
June 30, 2025 1.453B
March 31, 2025 1.282B
December 31, 2024 1.390B
September 30, 2024 1.209B
June 30, 2024 1.177B
March 31, 2024 1.071B
December 31, 2023 1.003B
September 30, 2023 866.84M
June 30, 2023 829.22M
March 31, 2023 703.89M
December 31, 2022 808.60M
September 30, 2022 1.004B
June 30, 2022 1.126B
March 31, 2022 937.20M
December 31, 2021 992.69M
September 30, 2021 834.51M
June 30, 2021 838.36M
March 31, 2021 759.96M
December 31, 2020 758.15M
September 30, 2020 787.45M
June 30, 2020 670.45M
Date Value
March 31, 2020 904.73M
December 31, 2019 1.103B
September 30, 2019 805.21M
June 30, 2019 870.05M
March 31, 2019 845.67M
December 31, 2018 823.31M
September 30, 2018 793.99M
June 30, 2018 779.30M
March 31, 2018 699.52M
December 31, 2017 789.23M
September 30, 2017 680.91M
June 30, 2017 637.35M
March 31, 2017 613.30M
December 31, 2016 729.68M
September 30, 2016 719.31M
June 30, 2016 844.50M
March 31, 2016 748.04M
December 31, 2015 921.81M
September 30, 2015 910.08M
June 30, 2015 1.038B
March 31, 2015 1.095B
December 31, 2014 1.330B
September 30, 2014 1.324B
June 30, 2014 1.344B
March 31, 2014 1.843B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Archer Ltd. 262.60M
Akastor ASA 16.53M
Subsea 7 SA 1.925B
Core Laboratories, Inc. 124.61M
Archrock, Inc. 371.24M